Facial Emotion Recognition in Patients Who Committed Sexual Assault Against Children: an EEG Study
NCT ID: NCT05383235
Last Updated: 2025-07-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
30 participants
INTERVENTIONAL
2022-07-12
2025-05-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Detection of Arousal With Facial Micro-expression in Severe Brain-damaged Patient
NCT03023657
Facial Expression Recognition of Emotion and Categorization of Emotional Words in Gilles de la Tourette's Syndrome
NCT00664300
Brain and Oculometric Markers of Emotional Facial Expression Recognition Deficits
NCT05501405
Tactile Stimulation in Disorders of Consciousness (DoC)
NCT06922123
Neurophysiological Study of Sensory and Cognitive Processes in Healthy Children and Adults
NCT03182400
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Facial emotion recognition capacities, that play a major role in social cognition and generation of appropriate social behavior, has been the subject of few studies in sexual offenders. These studies show heterogeneous results and only one of them specifically targets sexual offenders against children. Furthermore, no study has investigated facial emotion recognition in this population with an objective measurement of emotional processing, such as electroencephalographic (EEG) activity. LPP (late positive potential) amplitude, measured in EEG, is a marker of emotional processing and appears to be modified in particular populations (eg. psychopaths) in response to negative visual stimuli compared to positive stimuli.
The investigators aim to determine whether LPP amplitude in response to negative facial expressions is modified in sexual offenders against children compared to healthy volunteers and compared to amplitude in response to positive facial expressions.
Effect of facial emotion characteristics (type of emotion, age and sex of person expressing the emotion) on EEG response will be assessed.
Various neuropsychological and cognitive characteristics (facial emotion recognition, theory of mind, psychopathic traits, childhood trauma, and alexithymia) of patients and controls will also be measured through neuropsychological evaluation and completion of scales and questionnaires, in order to investigate the impact of those factors on facial emotion recognition performances.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
1. ROUTINE CARE : retrieval of sociodemographic characteristics, medical and psychological assessment, multidisciplinary meeting
2. RUN-IN PERIOD:
* Eligibility criteria will be assessed during the multidisciplinary meeting
* Delivery of the information note
3. STUDY:
* Collection of consent form
* Facial emotion stimuli presentation task with EEG recording and facial emotion recognition task
* Neuropsychological evaluation
* Scales + questionnaires
* Debriefing
CONTROLS:
1. RUN-IN PERIOD phone call:
* Study presentation
* Retrieval of sociodemographic characteristics including age and educational level for matching with patients
* Assessment of eligibility criteria
* Psychiatric assessment with MINI 5.0 evaluation
2. STUDY:
* Delivery of the information note
* Collection of consent form
* Facial emotion stimuli presentation task with EEG recording and facial emotion recognition task
* Neuropsychological evaluation
* Scales + questionnaires
* Debriefing
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Sexual offenders against children
sexual offenders against children
ROUTINE CARE
1\. ROUTINE CARE : retrieval of sociodemographic characteristics, medical and psychological assessment, multidisciplinary meeting about the patient
Facial emotion stimuli prensentation task with EEG recording and facial emotion recognition task
2\. RUN-IN PERIOD :
* Eligibility criteria will be assessed during the multidisciplinary meeting;
* Study presentation, delivery of the information note and consent form; 3. STUDY:
* Collection of consent form;
* Facial emotion stimuli presentation task with EEG recording and facial emotion recording task;
* Neuropsychological evaluation (TOM-15);
* Scales and questionnaires (TAS-20, PCL-R SV, CECAQ, QCAE);
* Debriefing.
Healthy controls
Healthy controls
Facial emotion stimuli prensentation task with EEG recording and facial emotion recognition task
2\. RUN-IN PERIOD :
* Eligibility criteria will be assessed during the multidisciplinary meeting;
* Study presentation, delivery of the information note and consent form; 3. STUDY:
* Collection of consent form;
* Facial emotion stimuli presentation task with EEG recording and facial emotion recording task;
* Neuropsychological evaluation (TOM-15);
* Scales and questionnaires (TAS-20, PCL-R SV, CECAQ, QCAE);
* Debriefing.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ROUTINE CARE
1\. ROUTINE CARE : retrieval of sociodemographic characteristics, medical and psychological assessment, multidisciplinary meeting about the patient
Facial emotion stimuli prensentation task with EEG recording and facial emotion recognition task
2\. RUN-IN PERIOD :
* Eligibility criteria will be assessed during the multidisciplinary meeting;
* Study presentation, delivery of the information note and consent form; 3. STUDY:
* Collection of consent form;
* Facial emotion stimuli presentation task with EEG recording and facial emotion recording task;
* Neuropsychological evaluation (TOM-15);
* Scales and questionnaires (TAS-20, PCL-R SV, CECAQ, QCAE);
* Debriefing.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient refered to the referral platform for treatment of sexual offenders in Le Vinatier Hospital Center for evaluation of child abuse ;
* Without any Axis 1 disorder ;
* Having given informed consent ;
* Affiliated to French social health care
* Right-handed ;
* Without criminal background ;
* Without any DSM-5 psychiatric disorder (past or present, personal or familial in a first-degree relative) ;
* Non-caregiver employee of Le Vinatier Hospital Center.
Exclusion Criteria
* Poor understanding of tests and scales instructions ;
* Neurological or neurodevelopmental history resulting in cognitive impairment with loss of autonomy ;
* Gardianship or other tutelage measure
Healthy controls :
* Intellectual disability (using fNART if clinical suspicion during run-in period);
* Poor understanding of tests and scales instructions ;
* Neurological or neurodevelopmental history resulting in cognitive impairment with loss of autonomy ;
* Gardianship or other tutelage measure.
25 Years
55 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hôpital le Vinatier
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sabine MOUCHET, PH
Role: PRINCIPAL_INVESTIGATOR
CH le Vinatier
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Hospitalier Le Vinatier
Bron, Auvergne-Rhône-Alpes, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021-A02763-38
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.